Epidiolex — Medical Mutual
Dravet Syndrome (Severe Myoclonic Epilepsy in Infancy)
Initial criteria
- Patient is age ≥ 1 year
- Patient has tried or is concomitantly receiving one antiepileptic drug used for Dravet Syndrome OR patient has tried or is concomitantly receiving at least two other antiseizure medications
- Medication is prescribed by or in consultation with a neurologist
Reauthorization criteria
- Patient is currently receiving Epidiolex and is responding to therapy (e.g., reduced seizure activity, frequency, and/or duration) as determined by the prescriber
Approval duration
1 year